Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases (Q35172206)

6 August 2017

1 reference

title

Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

6 August 2017

0 references

1 reference

Allan Wiik

1

1 reference

6 August 2017

1 February 2002

1 reference

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

1-2

1 reference

6 August 2017

67-72

1 reference

DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

AN ANTINUCLEAR FACTOR SPECIFIC FOR LEUCOCYTES

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

"Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Lactoferrin: nuclear localization in the human neutrophilic granulocyte?

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Serologic testing for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2801%2900007-6

7 January 2021

10.1016/S1568-9972(01)00007-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12849061